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Abstract  
Background: While recommended in guidelines for the management of coronary heart disease 
(CHD), concerns have been raised about the applicability of evidence from existing meta-analyses of 
exercise-based cardiac rehabilitation (CR). 
Objective: To update the Cochrane systematic review and meta-analysis of exercise-based CR for 
CHD.  
Methods: Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL and Science 
Citation Index Expanded were searched to July 2014. Retrieved articles, systematic reviews, and trial 
registries were hand-searched. We included randomised controlled trials with at least six months 
follow-up, comparing CR to no exercise control in individuals following myocardial infarction or 
revascularisation, or with a diagnosis of angina pectoris or CHD defined by angiography. Two authors 
screened titles for inclusion, extracted data and assessed risk of bias. Stratified meta-analysis was 
undertaken to examine potential treatment effect modifiers. 
Results: Sixty three studies in 14,486 participants with median follow-up of 12 months, were 
included. Overall, CR led to a reduction in cardiovascular mortality (relative risk 0.74, 95% CI: 0.64 to 
0.85) and the risk of hospital admissions (relative risk 0.82, 0.70 to 0.96). There was no significant 
impact on total mortality, myocardial infarction or revascularisation. The majority of studies (13/20) 
showed higher levels of health-related quality of life  in one or more domains following exercise-
based CR compared to control. 
Conclusions: This study confirms that exercise-based CR reduces cardiovascular mortality and 
provides important data showing reductions in hospital admissions and improvements in quality of 
life. These benefits appear to be consistent across patients and intervention types and were 
independent of study quality, setting and publication date. 
Keywords 
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Abbreviations 
CHD = coronary heart disease 
CR = cardiac rehabilitation 
HRQL = health-related quality of life 
CABG = coronary artery bypass grafting 
PCI = percutaneous coronary intervention 
CV = cardiovascular 
MI = myocardial infarction 
RCT = randomised controlled trial 
RR =relative risk 
CI = confidence interval 
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Introduction 
With increasing numbers of people living longer with symptomatic coronary heart disease (CHD), the 
effectiveness and accessibility of health services for people with CHD have never been more 
important. Cardiac rehabilitation (CR) programmes are recognised as integral to comprehensive care 
of CHD patients and have been given a Class I recommendation from the American Heart 
Association,  and the American College of Cardiology, and the European Society of Cardiology, with 
exercise therapy consistently identified as a central element (1-4). While exercise training remains a 
cornerstone intervention, international guidelines consistently recommend the provision of 
comprehensive rehabilitation that includes education and psychological input focusing on health and 
lifestyle behaviour change, risk factor modification, and psychosocial well-being (1-3). 
The first systematic reviews and meta-analyses of exercise-based CR by Oldridge and O’Connor were 
published more than 20 years ago, showing a 20-25% reduction in all-cause and cardiovascular 
mortality based on data from 22 randomised controlled trials (RCTs) in over 4,300 patients (5,6).  
Although there have been more recent updates to these meta-analyses (7-9), concerns have been 
raised about the applicability of their results to policy planning and the provision of CR services 
(10,11).  It has been argued that major advances in CHD medical management may have led to a 
reduction in the incremental effect on mortality of exercise-based CR compared to usual care alone. 
Other concerns have included the inclusion of small, poor quality RCTs which may have resulted in 
overestimation of the benefits of CR, and the almost exclusive recruitment of low-risk, middle-aged 
post-myocardial infarction (MI) men in early trials, thereby reducing the generalisability of their 
findings to the broader population of CHD patients (12). Our aim was to systematically update 
existing meta-analyses to reassess the effects of exercise-based CR in patients with CHD in terms of 
mortality, morbidity, health-related quality of life (HRQL), and cost-effectiveness. We also sought to 
explore if effects vary with patient case mix, the nature of CR programmes, and study characteristics. 
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Methods   
We conducted and reported this systematic review in accordance with the PRISMA (Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses) statement (13) and the Cochrane 
Handbook for Interventional Reviews (14). The protocol was published on the Cochrane Database of 
Systematic Reviews (2001) (15).  
Data Searches and Sources 
Search terms from the 2011 Cochrane review (9) were updated and CENTRAL, DARE, HTA, MEDLINE 
& Medline in Process (OVID), EMBASE (OVID) and CINAHL Plus (EBSCO) were searched to July 2014. 
Conference proceedings were searched on Web of Science Core Collection (Thomson Reuters) (1970 
to June 2014) and bibliographies of systematic reviews and trial registers (WHO's ICTRP and 
Clinicaltrials.gov) were hand-searched. No language or other limitations were imposed (see online 
supplementary material). 
Study Selection 
Randomised controlled trials of exercise-based CR compared to a control with a follow-up period of 
at least six months were sought. Exercise-based CR was defined as a supervised or unsupervised 
inpatient, outpatient, community- or home-based intervention which includes some form of exercise 
training, either alone or in addition to psychosocial and/or educational interventions. The 
comparator could include standard medical care, and psychosocial and / or educational 
interventions, but not any structured exercise training. We included patients irrespective of gender 
or age, who have had an MI, or who had undergone revascularisation (coronary artery bypass 
grafting (CABG) or percutaneous coronary intervention (PCI)) or who have angina pectoris or CHD 
defined by angiography. Finally, studies needed to report one or more of the following outcomes: 
total or cardiovascular mortality; fatal or non-fatal MI; revascularisations (CABG or PCI); 
hospitalisations;  HRQL assessed using validated instruments; or costs and cost-effectiveness. Two 
reviewers (LA and RST) independently assessed all identified titles/abstracts for possible inclusion, 
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with any disagreements resolved by discussion. Where necessary, studies were translated into 
English.  
Data Extraction and Management   
One reviewer (LA) extracted study and patient characteristics, intervention and comparator details 
and outcome data from included studies using a standardised data collection form. A second author 
(RST) checked for accuracy and disagreements were resolved by consensus. Duplicate publications of 
the same study were assessed for additional data and authors were contacted where necessary to 
provide additional information. 
Assessment of Risk of Bias and Overall Quality of Evidence  
Risk of bias of included studies was assessed using the Cochrane Collaboration's core risk of bias 
items (14) and three further items deemed relevant to this review. GRADEProfiler software (16) was 
used to assess the overall quality of evidence for each outcome collected (17) (see eMethods for full 
details). 
Data Synthesis and Analysis 
Dichotomous outcomes were expressed as relative risks (RR) with 95% confidence intervals (CI). 
HRQL scores were expressed as mean differences.  Heterogeneity amongst included studies was 
explored qualitatively and quantitatively (using the chi-squared test of heterogeneity and I2 statistic). 
Data from each study were pooled using a fixed effect model, except where substantial 
heterogeneity was associated with an effect estimate (i.e. chi-squared test P value < 0.10, I2 > 30%), 
when a random effects model was applied.  
The meta-analysis of each outcome was stratified according to the duration of study follow-up i.e. 6 
to 12 months ('short-term'); 13 to 36 months ('medium- term'); and > 36 months ('long- term'). 
Using the longest follow-up, we stratified meta-analyses  to explore heterogeneity and examine 
potential treatment effect modifiers. We tested nine a priori hypotheses that there may be 
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differences in the effect of exercise-based CR on outcomes at longest follow-up across the following 
subgroups: (1) CHD case mix (MI-only trials versus other trials); (2) type of CR (exercise-only CR 
versus comprehensive CR); (3) 'dose' of exercise intervention [dose = number of weeks of exercise 
training x average number of sessions/week x average duration of session in minutes] (dose ≥ 1000 
units versus dose < 1000 units); (4) follow-up period; (5) year of publication; (6) sample size; (7) 
setting (home- or centre-based CR); (8) risk of bias (low risk of bias in < 5 out of 8 domains); and (9) 
study location (continent).  
The funnel plot and Egger test were used to examine small study bias (18). All statistical and analyses 
were performed using Review Manager 5.3 Software (19) and STATA V.13.0 (StataCorp, College 
Station, Texas) (20).  
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Results   
Selection and Inclusion of Studies  
The 2011 Cochrane review provided 47 RCTs (81 publications). Our searches for this update yielded 
11,028 titles of which 91 full papers were considered for inclusion. Sixteen new RCTs (21 
publications) were included giving a total of 63 studies (102 publications) (see Figure 1 for a 
summary of the study selection process and eTable 1 for a list of included studies).  
Study, Patient and Intervention Characteristics 
Fourteen studies were published before 1999 and 49 published since 2000 (Table 1). The median 
follow-up was 12 months, with 50 studies reporting at least 12-months follow-up and 18 reporting 
follow-up of 36 months or more.  The majority of studies were conducted in Europe (37 studies) or 
North America (12 studies). Although we included 14,486 patients, most studies were small in 
sample size (median 126, range: 28-2304), with two large multicentre centre trials (WHO and 
RAMIT) (12,21) contributing a total of 4,177 patients (about 30% of all participants).  
The median age of participants across studies was 56.0 years.  Although 42 studies (66%) included 
women, they accounted for less than 15% of all patients recruited.  Studies published since 2005 
were less dominated by post-MI patients, included other CHD diagnoses including revascularisation 
and angina, and were more likely to include older (average mean age 61.7 years vs 56.3 years) and 
female (20.0% vs 12.5%) participants. 
Exercise-based CR programmes were typically delivered in a supervised hospital/centre-based 
setting either exclusively, or in combination with some maintenance home exercise sessions. Fifteen 
studies were conducted in an exclusively home-based setting (22-36)(31,35). While the primary 
mode of exercise training across all studies was aerobic, the overall or average duration, frequency 
and intensity of sessions, varied considerably across studies. Twenty four studies were exercise-only 
programmes, 38 were comprehensive CR, and one trial included both exercise-only and 
comprehensive CR arms (37).   
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Risk of Bias and GRADE assessment 
The overall risk of bias across domains was judged to be low or unclear (see eTable 2). Quality of 
reporting was generally higher in more recent studies. Overall, the GRADE quality of evidence for 
each outcome was assessed to be low to moderate (Table 2).  
Outcome results 
As there was no difference in the impact of exercise-based CR on clinical outcomes across length of 
follow-up (Table 2), the following results focus on pooled findings across all trials at their longest 
follow-up (median 12 months).  
Mortality 
Forty seven studies (12,455 participants) reported total mortality (Table 2; eFigure 1). There was no 
statistically significant reduction in total mortality with exercise-based CR (relative risk (RR): 0.94, 
0.87 to 1.02, fixed effects) compared with no exercise control. Twenty seven studies (7469 
participants) reported cardiovascular mortality (Table 2; eFigure 2) and a statistically significant 
reduction in this outcome was seen compared with no exercise control (RR: 0.74, 0.64 to 0.85, fixed 
effects).  
Morbidity  
Thirty six studies (9717 participants) reported the risk of fatal or non-fatal MI (Table 2; eFigure 3), 
and no statistically significant difference in the risk of total MI was found with exercise based CR (RR: 
0.89, 0.78 to 1.02).  Twenty nine (5891 participants), and 16 (4012 participants) studies reported the 
risk of CABG and PCI, respectively (Table 2, eFigure 4 and eFigure 5). There was no difference 
between exercise-based CR and usual care for either CABG or PCI (CABG: RR: 0.94, 0.78 to 1.12; PCI: 
RR: 0.86, 0.71 to 1.04, fixed effects). Fifteen studies (2865 participants) reported hospital admissions 
(Table 2; eFigure 6). Risk of admissions was reduced with exercise-based CR compared with usual 
care (RR: 0.82, 0.70 to 0.96, random effects).  There was no evidence of statistical heterogeneity 
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across trials in either mortality or morbidity outcomes (with exception of hospitalisations (I2 statistic 
=35%). 
Stratified meta-analyses 
There was with no evidence of difference in CR vs control treatment effects across mortality and 
morbidity outcomes across any patient, intervention or study characteristics (Table 3).  
Health-Related Quality of Life 
Twenty studies (5,060 participants) assessed HRQL using a range of validated generic or disease-
specific outcome measures (eTable 3). Given both the heterogeneity in outcome measures and 
methods of reporting the findings, we did not undertake meta-analysis. Thirteen out of the 20 
studies (65%) reported a higher level of  HRQL in one or more sub-scale following exercise-based CR 
compared with control (23,27,29,31,33,35,36,38-43), and in five studies (25%) there was a higher 
level of HRQL in half or more of the sub-scales (23,33,35,36,38). 
Costs and Cost-Effectiveness 
Seven studies reported data on costs (31,40,44-48) (eTable 4).  Three studies showed no difference 
in total healthcare costs between CR and control groups, (40,44,46), one reported lower healthcare 
costs for CR compared with usual care (reduction of US$2378/patient) (47) while another reported 
higher healthcare costs for CR (increase of $US4,839 /patient) (45), and two studies did not report 
total healthcare costs (31,48). Cost-effectiveness ranged from an additional $US42,535 per quality 
adjusted life year (QALY) (40) for CR to a reduction of US$650 per QALY (46) for CR compared to 
control.  
Small Study Bias 
There was no evidence of funnel plot asymmetry or significant Egger tests for mortality or 
revascularisation outcomes (eFigures 7, 8, 10, and 11). However, Egger tests were significant for MI 
(P = 0.009) and hospitalisation (P = 0.001) indicating funnel plot asymmetry. This asymmetry 
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appeared to be due to an absence of small to medium size studies with negative results for exercise-
based CR (eFigures 9 and 12). 
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Discussion   
We conducted an updated systematic review and meta-analysis of exercise-based CR in people with 
existing CHD. Our study  shows a reduction in pooled cardiovascular mortality (10.4% to 7.6%; 
number needed to treat: 37), and hospital admission (30.7% to 26.1%; number needed to treat: 22) 
with exercise-based CR compared to no exercise control. There was no between group difference in 
total mortality or the risk of  fatal or non-fatal MI, CABG, or PCI.  Outcome effects were consistent 
across RCTs irrespective of patient case mix (i.e. % of MI patients), the nature of CR programme (i.e. 
exercise-only or comprehensive CR; dose of exercise training; or centre- or home-based settings), 
and study characteristics (i.e. sample size; risk of bias; location; length of follow-up or year of 
publication). There was evidence of higher levels of HRQL following exercise-based CR compared to 
control and that exercise-based CR can be a cost-effective use of healthcare resources. 
In contrast to previous meta-analyses , we did not observe a statistically significant reduction in all-
cause mortality with exercise-based CR and this may be explained by the inclusion of more recent 
studies that include a more mixed population of CHD patients, conducted in the era of optimal 
medical therapy for CHD.  Our review included RCTs conducted over a period (1974 to 2014) during 
which there have been a number of major advances in medical CHD management, such as the 
increased use of statins. We found some support for this hypothesis in our meta-regression analysis 
that shows a trend of a linear reduction (slope: 0.0063, 95% CI: -0.00150 to 0.0141, P=0.08) in the 
all-cause mortality effect (log RR) of CR over time, i.e. study publication date (Figure 2). In spite of 
the observed improvements in cardiovascular mortality, in a context of contemporary CHD medical 
treatments, the opportunity for additional gains in overall mortality with exercise-based CR may be 
small. Nonetheless, the observation that exercise-based CR reduces the risk of cardiovascular 
mortality compared with no exercise control, but does not reduce the risk of MI or revascularization, 
suggests that while CR does not improve coronary vascular function or integrity,  it does confer 
improved survival in patients post- MI.  
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Limitations 
There are limitations to this systematic review. The generally poor level of reporting in the included 
RCTs made it difficult to assess their methodological quality and thereby judge their risk of bias. 
However, we did find some improvements in the quality of reporting in more recently published 
studies. Reassuringly our meta-analysis findings were consistent when limited to studies with a 
lower risk of bias. Nevertheless, the general paucity of reporting led to us downgrading the GRADE 
quality of evidence for outcomes to ‘low’ or ‘moderate’.  We acknowledge that the median outcome 
follow-up of 12 months is limited when assessing  for impact on mortality and morbidity outcome 
measures. However, our results were consistent when pooling was limited to RCTs with a follow up > 
12 months. Funnel plot asymmetry for the risk of MI and hospital admission is indicative of possible 
publication bias. Included RCTs did not consistently report all outcomes relevant to this review and 
events were often reported in study description of drop out or withdrawal. Reassuringly we found 
our overall meta-analysis results to be consistent in the subgroup of 20 studies reporting both 
mortality outcomes (all-cause mortality RR: 0.91, 95% CI: 0.82 to 1.01; CV mortality RR: 0.78, 95%: 
0.67 to 0.90). The minority of trials reported non-cardiovascular causes of death. Only more recent 
studies have begun to consistently report data on hospitalisations, but still often fail to differentiate 
between new and recurrent admissions, while HRQL and cost data are still collected infrequently. 
Finally, we sought to categorise the diagnoses of study participants according to a more detailed 
framework based on Braunwald's classification of CHD (49) to study whether the effect of exercise-
based CR differs according to the presentation i.e. acute coronary syndrome (MI, Non ST-segment 
elevation MI [NSTEMI], unstable angina pectoris) and stable angina pectoris or treatment modality 
(PCI, CABG or medication alone). The limited reporting by RCTs of inclusion and exclusion criteria 
and participant characteristics prevented us applying this categorisation. Nevertheless, we believe 
this to be the most comprehensive review of evidence to date and summarises the results of RCTs in 
>14000 patients.  
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Conclusions   
Among patients with established CHD, provision of exercise-based CR provides important health 
benefits that include reductions in cardiovascular mortality and hospitalisation (and associated 
healthcare costs), and improvements in HRQL. Based on a meta-analysis of RCTs, these results 
support the level I recommendation of current international clinical guidelines that CR should be 
offered to CHD patients. However, future trials need to pay increased attention to the recruitment 
of patients that are more representative of the broader CHD population, including those at higher 
risk and with major co-morbidities, plus those with stable angina, and also improve their quality of 
reporting, particularly in terms of risk of bias, details of the intervention and control, and clinical 
events, HRQL, and health economic outcomes.   
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Perspectives 
COMPETENCIES IN MEDICAL KNOWLEDGE: Exercise-based CR reduces the risk of cardiovascular 
mortality and hospital admissions, and improves HRQL in patients with established CHD. These 
benefits appear to be independent of setting, intervention, study risk of bias, and patient 
characteristics.  
COMPETENCY IN PATIENT CARE: Exercise-based CR is effective and safe in the management of low- 
to moderate-risk post-MI or revascularisation patients, or those with stable angina. 
TRANSLATIONAL OUTLOOK: Future RCTs of CR need to be better reported and recruit a broader 
population of CHD patients, including those at higher risk and with major co-morbidities.   
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Figure 1. Summary of study selection process 
 
The 63 studies in this review included 47 studies (81 publications) from the 2011 version of the 
review, and a further 16 studies (21 publications) identified from the updated searches. 
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Figure 2. Meta-regression analysis of effect of CR on total mortality over time 
 
Plot of treatment effect (log RR) of exercise-based CR on total mortality effect versus study 
publication year.  The straight line indicates the treatment effect (log RR) of exercise-based CR on 
total mortality effect versus study publication year. The area of each data point is inversely related 
to the standard error of log RR.  
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Table 1. Summary of Trial and Patient Characteristics (63 included studies) 
 Number of studies (%) 
or Median* (Range) 
Study Characteristics  
Publication year 
1970–1979  
1980–1989  
1990–1999  
2000–2009  
2010 onwards 
 
2 (3)  
12 (19)  
20 (32)  
21 (33) 
8 (13) 
Study location 
Europe 
North America 
Asia 
Australasia 
Other  
Not reported 
 
37 (59) 
12 (19) 
6 (10) 
5 (8) 
2 (3) 
1 (2) 
Single centre 45 (71) 
Sample size 126 (28 to 2304) 
Duration of follow-up 12 months (6 to 120) 
Population Characteristics 
Gender  
Males only  
Females only  
Both males and female 
Not reported 
 
18 (29) 
1 (2) 
41 (65) 
3 (5) 
Age (years) 56.0 (49.3 to 71.0) 
Diagnosis  
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Post-myocardial infarction only  
Revascularization only  
Angina only 
Mixed CHD population 
31 (49) 
2 (3) 
5 (8) 
25 (40) 
Intervention Characteristics 
Intervention type 
Exercise-only programmes 
Comprehensive programmes 
 
25†
 
(38) 
39† (60) 
Duration  of intervention (months)  6 (1 to 48) 
Dose of intervention  
Duration 
Frequency 
Length 
Intensity 
 
6 months (1 to 48) 
1 to 7 sessions/week 
20 to 90 minutes/session 
 50% to 85% of maximal heart rate 
 50% to 95% of maximal oxygen 
uptake (VO2 max)  
 Borg rating of 11 to 15 
Setting 
Centre-based only 
Combination of Centre- and home-based  
Home-based only 
Not reported 
 
33 (52) 
13 (21) 
15 (24) 
2 (3) 
* Median of study means; †one study includes both exercise only and comprehensive CR arms 
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Table 2. Summary of meta-analysis effects of exercise-based CR on clinical event outcomes 
Outcome  
 
Number of 
participants  
(Number of 
Studies) 
Number of Events/ 
Participants 
Relative risk (95% CI) Statistical 
Heterogeneity  
I
2 
statistic 
Chi
2
-test  
(P value) 
GRADE 
Quality of 
the 
Evidence  
Intervention Comparator 
All-cause mortality (All Studies) 
 
12455 (47) 838/6424  865/6031 0.94 [0.87 to 1.02] 
 
0%  (0.58) ⊕⊕⊕⊝ 
moderate
*
 
Follow-up of 6 to 12 months 8800 (29) 226/4573 238/4227 0.87 [0.73, 1.03] 0% (0.82)  
Follow-up of > 12 to 36 
months 
6823 (13) 338/3495 417/3328 0.89 [0.78, 1.01] 0% (0.47) 
 
Follow-up longer than 3 years 3828 (11) 476/1902 493/1926 0.98 [0.88, 1.08] 35% (0.12)  
CV mortality (All Studies) 7469 (27) 292/3850 375/3619 0.74 [0.64 to 0.85] 0% (0.70) ⊕⊕⊕⊝ 
moderate
*
 
Follow-up of 6 to 12 months 4884 (15) 105/2561 107/2323 0.89 [0.69, 1.15] 0% (0.72)  
Follow-up of > 12 to 36 
months 
3833 (7) 199/1971 239/1862 0.78 [0.65, 0.93] 5% (0.38) 
 
Follow-up longer than 3 years 1392 (8) 56/690 100/702 0.56 [0.42, 0.76] 0% (0.91)  
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Fatal and/or non-fatal MI (All 
Studies) 
971 (36) 
  
356/4951 387/4766 0.89 [0.78 to 1.02] 0% (0.48) ⊕⊕⊝⊝ 
low*,† 
Follow-up of 6 to 12 months 6911 (20) 126/3543 139/3368 0.86 [0.68, 1.09] 0% (0.58)  
Follow-up of > 12 to 36 
months 
5644 (11) 251/2877 222/2767 1.08 [0.91, 1.28] 0% (0.72) 
 
Follow-up longer than 3 years 1560 (10) 65/776 102/784 0.65 [0.49, 0.87] 0% (0.67)  
CABG (All Studies) 5891 (29)
  
208/3021 212/2870 0.94 [0.78 to 1.12] 0% (0.86) ⊕⊕⊕⊝ 
moderate
*
 
Follow-up of 6 to 12 months 4563 (21) 123/2351 121/2212 0.95 [0.75, 1.20] 0% (0.83)  
Follow-up of > 12 to 36 
months 
2755 (98) 122/1379 123/1376 0.99 [0.78, 1.25] 0% (0.93) 
 
Follow-up longer than 3 years 675 (4) 19/333 29/342 0.65 [0.37, 1.13] 18% (0.30)  
PCI (All Studies) 4012 (16) 171/2013 197/1999 0.86 [0.71 to 1.04] 0% (0.59) ⊕⊕⊕⊝ 
moderate
*
 
Follow-up of 6 to 12 months 3564 (13) 90/1778 99/1786 0.92 [0.70, 1.20] 16% (0.30)  
Follow-up of > 12 to 36 
months 
1983 (6) 114/996 116/987 0.96 [0.76, 1.22] 26% (0.24) 
 
Follow-up longer than 3 years 567 (3) 28/281 37/286 0.75 [0.48, 1.19] 0% (0.81)  
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Hospital admissions (All Studies) 3030  (15)
  
407/1556 453/1474 0.86 [0.77 to 0.95] 34.5% (0.10) ⊕⊕⊝⊝ 
low*,† 
Follow-up of 6 to 12 months 1120 (9) 82/574 116/546 0.65 [0.46, 0.92] 37% (0.14)  
Follow-up of > 12 to 36 
months 
1916 (6) 322/984 330/932 0.95 [0.84, 1.07] 0% (0.50) 
 
Follow-up longer than 3 years 0 (0) 0/0 0/0 Not estimable Not estimable  
Footnotes 
*
 Random sequence generation, allocation concealment or blinding of outcome assessors were poorly described in over 50% of included studies; bias likely 
† Funnel Plots and / or Egger test suggest evidence of asymmetry 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect. 
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
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Table 3. Stratified meta-analysis by patient, intervention and study characteristics at longest follow up 
 All-cause mortality CV mortality MI CABG PCI Hospitalisation 
 RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) 
All studies 0.94 (0.87 to 1.02) 0.74 (0.64 to 0.85) 0.89 (0.78 to 1.02) 0.94 (0.78 to 1.12) 0.86 (0.71 to 1.04) 0.86 (0.77 to 0.95) 
 
Stratified analyses 
Case mix       
100% MI 0.91 (0.82 to 1.00)  0.75 (0.64 to 0.87) 0.91( 0.79 to 1.05) 1.06( 0.86 to 1.30) 0.87 (0.67 to 1.14) 0.90 (0.73 to 1.09) 
< 100% MI 1.02 (0.88 to 1.18)  0.616 (0.378 to 1.01) 0.68 (0.42 to 1.10) 0.63(0.43 to 0.93) 0.84 (0.64 to 1.11) 0.84 (0.74 to 0.96) 
Dose of exercise*       
< 1000 1.00 (0.49 to 2.04) 0.47 (0.19 to 1.15) 0.72 (0.32 to 1.62) 0.96 (0.46 to1.99) 1.22 (0.34 to 4.34) 0.67 (0.45 to 0.99) 
≥ 1000 0.99 (0.87 to 1.13) 0.71 ( 0.56 to 0.91) 0.73 (0.59 to 0.91) 0.96 (0.76 to 1.21) 0.81 (0.63 to 1.03) 0.88 (0.78 to 0.98) 
Type of CR        
Exercise only 0.98 (0.86 to 1.13) 0.63 (0.49 to 0.82) 0.76 (0.60 to 0.97) 0.91 (0.64 to 1.29) 1.03 (0.54 to 1.97) 0.85 (0.70 to 1.04) 
Comprehensive CR 0.92 (0.829 to1.02) 0.78 (0.66 to 0.93) 0.96 (0.81 to 1.13) 0.95 (0.77 to 1.17) 0.87 (0.71to 1.07) 0.86 (0.76 to 0.98) 
Duration of follow months (months)      
≤ 12 months 1.06 (0.52 to 2.18) 0.71 (0.61 to 0.83) 0.60 (0.40 to 0.90) 0.96 (0.70 to 1.32) 0.85 (0.56 to 1.30) 0.64 (0.49 to 0.83) 
> 12months 0.95 (0.86 to 1.02) 0.98 (0.63 to 1.52) 0.94 (0.81 to 1.09) 0.92 (0.74 to 1.15) 0.86 (0.69 to 1.07) 0.92 (0.81 to 1.03) 
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Year of publication       
Pre 1995 0.86 (0.75 to 0.98) 0.78 (0.67 to 0.91) 0.96 (0.82 to 1.13) 0.87 (0.59 to 1.28) 0.80 (0.42 to 1.51) 0.88 (0.76 to 1.02) 
Post 1995  1.00 (0.903 to 1.11) 0.54 (0.37 to 0.80) 0.75 (0.58 to 0.97) 0.96 (0.78 to 1.18) 0.87 (0.71 to 1.06) 0.83 (0.71 to 0.97) 
Setting       
Centre 0.94 (0.86 to 1.02) 0.75 (0.65 to 0.87) 0.96 (0.83 to 1.11) 0.97 (0.77 to 1.22) 0.93 (0.73 to 1.18) 0.89 (0.78 to 1.02) 
Centre plus home 0.72 (0.39 to 1.36) 0.63 (0.34 to 1.16) 0.36 (0.13 to 0.99) 0.74 (0.45 to 1.23) 0.62 (0.35 to 1.08) 0.86 (0.61 to 1.21) 
Home  1.01 (0.68 to 1.50) 0.89 (0.43 to 1.81) 0.48 (0.28 to 0.83) 1.07 (0.75 to 1.53) 0.79 (0.53 to 0.18) 0.76 (0.60 to 0.95) 
Risk of bias       
Low (bias in <5 out of 
8 domains) 
1.00 (0.87 to 1.16) 0.91 (0.28 to 2.95) 0.95 (0.69 to 1.31) 0.91( 0.69 to 1.20) 0.91(0.70 to 1.17) 0.89 (0.73 to 1.08) 
High (bias in > 5 out 
of 8 domains) 
0.91 (0.82 to 1.00) 0.74 (0.64 to 0.85) 0.75 (0.42 to 1.33) 0.96 (0.76 to 1.21) 0.80 (0.60 to 1.07) 0.84 (0.74 to 0.96) 
Study location (continent)      
Europe 0.91 (0.82 to 1.01) 0.74 (0.63 to 0.86) 0.93 (0.81to 1.08) 0.91 (0.72 to 1.14) 0.92 (0.73 to 1.15) 0.77 (0.66 to 0.91) 
North America 1.10 (0.94 to 1.28) 0.89 (0.57 to 1.40) 0.62 (0.41 to 0.93) 1.04 (0.77 to 1.39) 0.78 (0.52 to 1.16) 0.95 (0.80 to 1.11) 
Australasia NR 0.33 (0.01 to 7.87) 1.95 (0.36 to 10.49) 0.32 (0.07 to 1.55) 0.98 (0.33 to 2.93) 1.07 (0.74 to 1.55) 
Other 0.61 (0.34 to 1.05) 0.58 (0.32  to 1.08) 0.25 (0.01 to 5.91) NR NR 0.27 (0.10 to 0.74) 
Sample size       
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≤ 150 0.95 (0.87 to 1.03) 0.59 (0.35 to 0.98) 0.56 (0.37 to 0.82) 0.73 (0.50 to 1.06) 0.82 (0.54 to 1.24) 0.60 (0.46 to 0.78) 
> 150 0.76 (0.50 to 1.15) 0.76 (0.65 to 0.88) 0.95 (0.82 to 1.10) 1.02 (0.83 to 1.25) 0.87 (0.70 to 1.08) 0.93 (0.83 to 1.05) 
NR – not measurable; CV mortality – cardiovascular mortality; MI – myocardial infarction; CABG – coronary artery bypass graft; PI – percutaneous intervention; RR – 
relative risk 
* number of weeks of exercise training x average number of sessions/week x average duration of session in min 
 
 
